Literature DB >> 28495218

Effects of hippocampal low-frequency stimulation in idiopathic non-human primate epilepsy assessed via a remote-sensing-enabled neurostimulator.

Thomas A Wozny1, Witold J Lipski1, Ahmad Alhourani1, Efstathios D Kondylis1, Arun Antony2, R Mark Richardson3.   

Abstract

Individuals with pharmacoresistant epilepsy remain a large and under-treated patient population. Continued technologic advancements in implantable neurostimulators have spurred considerable research efforts directed towards the development of novel antiepileptic stimulation therapies. However, the lack of adequate preclinical experimental platforms has precluded a detailed understanding of the differential effects of stimulation parameters on neuronal activity within seizure networks. In order to chronically monitor seizures and the effects of stimulation in a freely-behaving non-human primate with idiopathic epilepsy, we employed a novel simultaneous video-intracranial EEG recording platform using a state-of-the-art sensing-enabled, rechargeable clinical neurostimulator with real-time seizure detection and wireless data streaming capabilities. Using this platform, we were able to characterize the electrographic and semiologic features of the focal-onset, secondarily generalizing tonic-clonic seizures stably expressed in this animal. A series of acute experiments exploring low-frequency (2Hz) hippocampal stimulation identified a pulse width (150μs) and current amplitude (4mA) combination which maximally suppressed local hippocampal activity. These optimized stimulation parameters were then delivered to the seizure onset-side hippocampus in a series of chronic experiments. This long-term testing revealed that the suppressive effects of low-frequency hippocampal stimulation 1) diminish when delivered continuously but are maintained when stimulation is cycled on and off, 2) are dependent on circadian rhythms, and 3) do not necessarily confer seizure protective effects.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Closed-loop stimulation; Deep brain stimulation; Electrical stimulation; Epilepsy; Hippocampus; Local field potential; Low-frequency stimulation; Non-human primate; Open-loop stimulation; Sensing-enabled neurostimulator

Mesh:

Year:  2017        PMID: 28495218     DOI: 10.1016/j.expneurol.2017.05.003

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  5 in total

Review 1.  Closed-Loop Brain Stimulation and Paradigm Shifts in Epilepsy Surgery.

Authors:  R Mark Richardson
Journal:  Neurol Clin       Date:  2022-03-31       Impact factor: 3.787

Review 2.  Closed-Loop Brain Stimulation for Drug-Resistant Epilepsy: Towards an Evidence-Based Approach to Personalized Medicine.

Authors:  Nathaniel D Sisterson; Thomas A Wozny; Vasileios Kokkinos; Alexander Constantino; R Mark Richardson
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

3.  PELP: Accounting for Missing Data in Neural Time Series by Periodic Estimation of Lost Packets.

Authors:  Evan M Dastin-van Rijn; Nicole R Provenza; Gregory S Vogt; Michelle Avendano-Ortega; Sameer A Sheth; Wayne K Goodman; Matthew T Harrison; David A Borton
Journal:  Front Hum Neurosci       Date:  2022-07-07       Impact factor: 3.473

Review 4.  Totally Implantable Bidirectional Neural Prostheses: A Flexible Platform for Innovation in Neuromodulation.

Authors:  Philip A Starr
Journal:  Front Neurosci       Date:  2018-09-07       Impact factor: 4.677

5.  Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson's disease.

Authors:  Ro'ee Gilron; Simon Little; Randy Perrone; Robert Wilt; Coralie de Hemptinne; Maria S Yaroshinsky; Caroline A Racine; Sarah S Wang; Jill L Ostrem; Paul S Larson; Doris D Wang; Nick B Galifianakis; Ian O Bledsoe; Marta San Luciano; Heather E Dawes; Gregory A Worrell; Vaclav Kremen; David A Borton; Timothy Denison; Philip A Starr
Journal:  Nat Biotechnol       Date:  2021-05-03       Impact factor: 54.908

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.